Clinical Trials for Adrenal Cancer
Clinical trials are research studies conducted in an effort to improve overall patient health and care.
Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition.
Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks.
A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.
A brief description of each phase:
- Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
- Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
- Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
- Phase IV: These studies monitor long-term side effects after the treatment has been marketed.
Clinical Trials data for Adrenal Cancer is grouped into the following categories:-
The format for each of the following is:
- The name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
- followed by a list of drug/s, if any, used in the trial
ClinicalTrials.gov has listed the following trials for Adrenal Cancer:
- Study of Adrenal Gland Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening - This study is currently recruiting patients (Current: 23 Nov 2006) - I-131 Iodocholesterol
- A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection - This study has been completed (Current: 23 Nov 2006)
- Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - hydrocortisone,suramin
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - antineoplaston A10,antineoplaston AS2-1
- Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - doxorubicin hydrochloride,etoposide,mitotane,tariquidar,vincristine
- Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) - This study is currently recruiting patients (Current: 23 Nov 2006) - Etoposide,Doxorubicin,Cisplatin,Streptozotocin,Mitotane
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - cisplatin,doxorubicin hydrochloride,etoposide,filgrastim,mitotane,pegfilgrastim
- Trial With Taxotere and Cisplatin in Non-Operable Adrenocortical Carcinoma - This study is currently recruiting patients (Current: 23 Nov 2006) - cisplatin,taxotere
The format for each of the following is:
- The drug,
- followed by the name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
ClinicalTrials.gov has listed the following drugs in trials for Adrenal Cancer:
- Antineoplaston A10 - Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Antineoplaston As2-1 - Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Cisplatin - Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Cisplatin - Trial With Taxotere and Cisplatin in Non-Operable Adrenocortical Carcinoma - This study is currently recruiting patients (Current: 23 Nov 2006)
- Cisplatin - Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) - This study is currently recruiting patients (Current: 23 Nov 2006)
- Doxorubicin Hydrochloride - Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Doxorubicin Hydrochloride - Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Doxorubicin - Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) - This study is currently recruiting patients (Current: 23 Nov 2006)
- Etoposide - Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Etoposide - Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Etoposide - Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) - This study is currently recruiting patients (Current: 23 Nov 2006)
- Filgrastim - Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Hydrocortisone - Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- I-131 Iodocholesterol - Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening - This study is currently recruiting patients (Current: 23 Nov 2006)
- Mitotane - Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Mitotane - Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Mitotane - Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) - This study is currently recruiting patients (Current: 23 Nov 2006)
- Pegfilgrastim - Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Streptozotocin - Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) - This study is currently recruiting patients (Current: 23 Nov 2006)
- Suramin - Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Tariquidar - Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Taxotere - Trial With Taxotere and Cisplatin in Non-Operable Adrenocortical Carcinoma - This study is currently recruiting patients (Current: 23 Nov 2006)
- Vincristine - Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
The trial data on this page has been sourced from
When prostate cancer no longer responds to hormonal therapy, it is called hormone refractory prostate cancer. Learn who's at risk for this stage...
Learn about hormone refractory prostate cancer and the current treatments that have can help improve quality of life.
Whenever you go to a hospital or clinic for a major procedure or diagnostic test, one of the many forms you are given to sign is an "informed...
Sexual contact can sometimes result in problems. An unwanted pregnancy or sexually transmitted diseases may be some of those consequences. But by...
See full list of 4 related videos
» Next page: Adrenal Insufficiency (A Pocket Manual of Differential Diagnosis)
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
